New stem cell treatment gains approval to enter US clinical trials
News
The latest news from Retina UK. Please use the filters to find the articles which interest you.
New Chair of Trustees
We are delighted to welcome Kathy Evans as our new Chair of Trustees.
A new approach to treating inherited sight loss
jCyte have released additional preclinical data regarding jCell
Researchers discovered a method to reduce Luxturna injection-related inflammation, improving safety and potentially preventing chorioretinal atrophy.
Applications invited for project grants and studentships
Retina UK invites applications for funding for innovative, high quality research projects investigating the causes and potential treatments for all forms of inherited retinal disease. We are particularly keen to receive proposals with demonstrable translational potential.
TPT and Sight Loss Councils: Cut it back campaign
Disulfiram (Antabuse), FDA-approved for deterring alcohol, is in a phase 1 trial at the University of Washington to improve vision in retinitis pigmentosa.
It was previously believed that female carriers of X-linked inherited retinal diseases (IRDs) like X-linked retinitis pigmentosa (RP and Choroideremia) remained unaffected by sight loss.